Clinical Trial Update: Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting the efficacy and safety results of MK-1942 as an adjunct therapy in people with mild-to-moderate Alzheimer's disease dem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• MK-1942

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2024-10-15